Brief: Else Nutrition Holdings Receives IRB Approval For Infant Growth Clinical Study Protocol
08/02/2023 12:16
Feb 8 (Reuters) - Else Nutrition Holdings Inc BABY.TO :
* ELSE NUTRITION RECEIVES IRB APPROVAL FOR INFANT GROWTH
CLINICAL
STUDY PROTOCOL
Source text for Eikon: ID:nGNX8dfDxx
Further company coverage: BABY.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Else Nutrition Holdings
See all newsBrief: Else Nutrition Pursuing Parallel Listing On Canadian Securities Exchange To Ensure Market Continuity
Canada's Else Nutrition Q1 revenue falls on supply issues
Brief: Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Brief: Else Nutrition Announces Appointment Of Natie Zilberberg As Chief Financial Officer
Brief: Else Nutrition Achieves Transformative Operational and Financial Progress in 2025